Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Short-term Investments: 2014-2025

Historic Short-term Investments for AC Immune (ACIU) over the last 11 years, with Sep 2025 value amounting to $100.9 million.

  • AC Immune's Short-term Investments fell 30.32% to $100.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $100.9 million, marking a year-over-year decrease of 30.32%. This contributed to the annual value of $100.9 million for FY2025, which is N/A change from last year.
  • As of FY2025, AC Immune's Short-term Investments stood at $100.9 million, which was up 68,316.50% from $147,501 recorded in FY2024.
  • In the past 5 years, AC Immune's Short-term Investments ranged from a high of $126.9 million in FY2021 and a low of $27,681 during FY2023.
  • Moreover, its 3-year median value for Short-term Investments was $147,501 (2024), whereas its average is $33.7 million.
  • Per our database at Business Quant, AC Immune's Short-term Investments slumped by 99.97% in 2023 and then spiked by 432.86% in 2024.
  • Yearly analysis of 5 years shows AC Immune's Short-term Investments stood at $126.9 million in 2021, then fell by 25.59% to $94.5 million in 2022, then plummeted by 99.97% to $27,681 in 2023, then skyrocketed by 432.86% to $147,501 in 2024, then reached $100.9 million in 2025.